June 30, 2025 11:16 AM EDT
Financing
Startups

Ap­ple Tree Part­ner­s' biotechs 'face im­mi­nent col­lapse' as firm bat­tles Russ­ian in­vestor in court

Kyle LaHucik

Biotech Correspondent

Ap­ple Tree Part­ners, a ven­ture firm and cre­ator of dozens of biotechs like Akero Ther­a­peu­tics and Chi­nook Ther­a­peu­tics, says mul­ti­ple port­fo­lio com­pa­nies are at risk …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: FDA pub­lish­es repos­i­to­ry of 200+ drug re­jec­tion let­ters, promis­ing more in the fu­ture

FDA hands Capri­cor a CRL for its Duchenne cell ther­a­py 

Sal­ly Sus­man waves good­bye to Pfiz­er; Xaira's new pres­i­dent and COO

Cen­tu­ry Ther­a­peu­tics lays off half of its staff, CFO de­parts as it nar­rows pri­or­i­ties

Biotech’s Q2 num­bers paint a pic­ture of the good, the bad and the ug­ly

sponsored

Un­cov­er­ing the Po­ten­tial of Tar­get­ing the CD38 Path­way for Im­mune-Me­di­at­ed Dis­eases

A service from the Financial Times